Both in Pharmaceuticals
Enanta Pharmaceuticals vs Canopy Growth
Over the past year ENTA returned −3.6% and CGC returned −43.3%; their daily moves had a correlation of 0.18.
ENTA −3.6% CGC −43.3%Growth of $1, one year, split-adjusted
| Metric | ENTA | CGC |
|---|---|---|
| Price | $10.43 | $0.6808 |
| Market cap | $303.8M | $288.0M |
| Today | −2.61% | +4.34% |
| 1 month | −19.5% | −22.2% |
| 6 months | −28.3% | −38.1% |
| Year to date | −33.9% | −40.3% |
| 1 year | −4.0% | −44.2% |
| Revenue growth (YoY) | −21.6% | +7.8% |
| Gross margin | 100.0% | 27.4% |
| Net margin | −135.8% | −18.0% |
| P/E (TTM) | — | — |
| Price / sales | 4.7× | 1.2× |
| Net cash | $189.5M | $67.9M |
| Dividend yield | — | — |
| Volatility (60d) | 45.5% | 40.9% |
| Short % of float | 8.2% | 7.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).